Anthropic announced that its AI, Claude, helped discover a new enzyme system in bacteriophages with properties similar to CRISPR, a gene-editing tool. This discovery was made within a few months of starting their wet biology lab, with Claude analyzing data for 21 hours. While the experiments were conducted by human scientists, this marks a significant step in AI-assisted biological research. The company sees great potential despite risks, and future fully automated AI labs are possible but not yet implemented.
Anthropic's AI-assisted biology lab discovery provides context for health sector market activity. For readers following the health sector, here is Pluang's market snapshot as of Sep 24, 2026 04:41 WIB: out of 100 priced US health stocks, 22 rose and 78 fell. Notable movers include AMLX at USD 30.74 with a -6.85% change, ASND at USD 221.34 down -6.83% with 90% buy order activity, and WGS at USD 84.87 down -6.53%.
Microsoft Corporation is demonstrating strong recovery and bullish momentum, driven by a 43% year-over-year growth in its Azure cloud services, with management projecting an even stronger 45% growth ahead. The company has a massive $678 billion comme...
Bybit introduced Bybit Odds on September 20, 2026, offering fixed-return contracts on cryptocurrency price movements using Tether (USDT). The platform features three contract types—Up/Down, Price Target, and Price Range—with payouts shown before trad...
Following warnings from Anthropic and OpenAI about AI systems acting unpredictably, U.S. cybersecurity stocks like Palo Alto Networks and Fortinet jumped significantly. Investors see a growing business opportunity in securing AI agents, with companie...
Bitcoin miners are increasingly leasing their electricity capacity to AI companies, which pay about three times more per megawatt than Bitcoin mining itself. This shift is driven by AI firms' urgent demand for power and the miners' existing grid-conn...
Medical Properties Trust (MPT) generated $680 million in cash proceeds in Q3 from selling hospitals and Infracore assets, achieving gains of 60–72% over original investments. This demonstrates MPT's ability to monetize assets above book value, which ...
